ScholarIQanswers from OpenAlex
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
InstitutionResearch output, impact & collaborations
Robert H. Lurie Comprehensive Cancer Center of Northwestern University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
ScholarIQrecord summary
Robert H. Lurie Comprehensive Cancer Center of Northwestern University is a research organisation in Chicago. OpenAlex records 6,877 works and 1,025,459 citations for it. 1,351 researchers list it as their most recent affiliation.
How many works does Robert H. Lurie Comprehensive Cancer Center of Northwestern University have?
ScholarIQindexed works
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has 6,877 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robert H. Lurie Comprehensive Cancer Center of Northwestern University have?
ScholarIQcitation count
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has 1,025,459 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
ScholarIQresearcher count
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has 1,351 researchers in the ScholarIQ index.
What is the average h-index at Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
ScholarIQavg h-index
Robert H. Lurie Comprehensive Cancer Center of Northwestern University has an average h-index of 122 in OpenAlex.
What is the ROR of Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
ScholarIQror
The ROR for Robert H. Lurie Comprehensive Cancer Center of Northwestern University is on the source record.
What is the OpenAlex record for Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
ScholarIQopenalex
The OpenAlex for Robert H. Lurie Comprehensive Cancer Center of Northwestern University is on the source record.
Who are the most-cited researchers behind Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
ScholarIQtop researchers by citations
What are the most-cited papers on Robert H. Lurie Comprehensive Cancer Center of Northwestern University?
ScholarIQmost cited works
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith, David F. McDermott, John D. Powderly, Richard D. Carvajal, Jeffrey A. Sosman, Michael B. Atkins, Philip D. Leming, David R. Spigel, Scott Antonia, Leora Horn, Charles G. Drake, Drew M. Pardoll, Lieping Chen, William H. Sharfman, Robert A. Anders, Janis M. Taube, Tracee L. McMiller, Haiying Xu, Alan J. Korman, Maria Jure–Kunkel, Shruti Agrawal, D. G. McDonald, Georgia Kollia, Ashok Gupta, Jon M. Wigginton, Mario Sznol
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Toni K. Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A.B. Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S. Simon, Li-An Xu, Ian M. Waxman, Padmanee Sharma
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Gary R. Hudes, Michael A. Carducci, Piotr Tomczak, Janice Dutcher, Robert A. Figlin, Anil Kapoor, Elżbieta Starosławska, Jeffrey A. Sosman, David McDermott, I. Bodrogi, Zoran Kovačević, Vladimir Lesovoy, Ingo G.H. Schmidt‐Wolf, О. Л. Барбараш, Erhan Gökmen, Timothy E. O’Toole, Stephanie Lustgarten, Laurence Moore, Robert J. Motzer
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
Scott Gettinger, Leora Horn, Leena Gandhi, David R. Spigel, Scott Antonia, Naiyer A. Rizvi, John D. Powderly, Rebecca S. Heist, Richard D. Carvajal, David M. Jackman, Lecia V. Sequist, David C. Smith, Philip D. Leming, David P. Carbone, Mary Pinder-Schenck, Suzanne L. Topalian, F. Stephen Hodi, Jeffrey A. Sosman, Mario Sznol, David F. McDermott, Drew M. Pardoll, Vindira Sankar, Christoph M. Ahlers, Mark Salvati, Jon M. Wigginton, Matthew D. Hellmann, Georgia Kollia, Ashok Gupta, Julie R. Brahmer
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su, Amaya Virós, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Olivia Spleiss, Jorge S. Reis‐Filho, Xiangju Kong, Richard C. Koya, Keith T. Flaherty, Paul B. Chapman, Min Jung Kim, Robert Hayward, Matthew J. Martin, Hong Yang, Qiongqing Wang, Holly Hilton, Julie S. Hang, Johannes Noé, Maryou Lambros, Felipe C. Geyer, Nathalie Dhomen, Ion Niculescu‐Duvaz, Alfonso Zambon, Dan Niculescu‐Duvaz, Natasha Preece, Lídia Robert, Nicholas Otte, Stephen Mok, Damien Kee, Yan Ma, Chao Zhang, Gaston Habets, Elizabeth A. Burton, Bernice H. Wong, Hoa Nguyen, Mark Kockx, Luc Andries, Brian Lestini, K. B. Nolop, Richard J. Lee, Andrew K. Joe, James L. Troy, René González, Thomas E. Hutson, Igor Puzanov, Bartosz Chmielowski, Caroline J. Springer, Grant A. McArthur, Jeffrey A. Sosman, Roger S. Lo, Antoni Ribas, Richard Marais
How much of the research on Robert H. Lurie Comprehensive Cancer Center of Northwestern University is open access?
ScholarIQopen access share
92%OPEN ACCESS